<!--- THIS FILE IS AUTOGENERATED. DO NOT EDIT IT. -->

[ [en](../solution.md) [ja](../ja/solution.md) [es](../es/solution.md) **pt**  ]

# Rumo a uma solução

Atualmente não existe uma solução para o SARS-CoV-2. 

Há, contudo, ideias sobre como as soluções poderiam ser. Uma vacina é uma possível solução, mas seu desenvolvimento leva tempo  [<a href="#citeref1">1</a>]. Também se fala em uso de soros (anticorpos) e reaproveitamento de drogas conhecidas. Tudo isso é muito exploratório nesse momento. Os ensaios clínicos são importantíssimos (consulte a seção [Ensaios clínicos](https://egonw.github.io/SARS-CoV-2-Queries/pt/covid.html#clinical-trials)).

Este capítulo mostra uma série de buscas de informações no Wikidata sobre agentes relacionados à busca de soluções para a COVID-19.

## Anticorpos

A busca por anticorpos eficazes tem ganhado bastante tração. A consulta a seguir enumera artigos sobre os coronavírus humanos também anotados com o termo '<a name="tp1">anticorpo</a>':

**SPARQL** [sparql/antibodies.rq](sparql/antibodies.code.html) ([run](https://query.wikidata.org/embed.html#SELECT%20%3Fvirus%20%3FvirusLabel%20%3Fwork%20%3FworkLabel%20WITH%20%7B%0A%20%20SELECT%20%3Fvirus%20%3Fwork%20WHERE%20%7B%0A%20%20%20%20VALUES%20%3Fvirus%20%7B%0A%20%20%20%20%20%20wd%3AQ82069695%20%23%20SARS-CoV-2%0A%20%20%20%20%20%20wd%3AQ16983360%20%23%20HKU1%0A%20%20%20%20%20%20wd%3AQ16991954%20%23%20OC43%0A%20%20%20%20%20%20wd%3AQ8351095%20%20%23%20NL63%20%0A%20%20%20%20%20%20wd%3AQ16983356%20%23%20229E%20%0A%20%20%20%20%20%20wd%3AQ4902157%20%20%23%20MERS-CoV%0A%20%20%20%20%20%20wd%3AQ278567%20%20%20%23%20SARS-CoV%0A%20%20%20%20%7D%0A%20%20%20%20%3Fwork%20wdt%3AP921%20%3Fvirus%20%3B%0A%20%20%20%20%20%20%20%20%20%20wdt%3AP921%20wd%3AQ79460%20.%0A%20%20%7D%0A%7D%20AS%20%25ARTICLES%20WHERE%20%7B%0A%20%20INCLUDE%20%25ARTICLES%0A%20%20SERVICE%20wikibase%3Alabel%20%7B%20bd%3AserviceParam%20wikibase%3Alanguage%20%22pt%2Cen%22.%20%7D%0A%7D%0AORDER%20BY%20%3FvirusLabel%20%3Fvirus%20%3FworkLabel%20%3Fwork%0A), [edit](https://query.wikidata.org/#SELECT%20%3Fvirus%20%3FvirusLabel%20%3Fwork%20%3FworkLabel%20WITH%20%7B%0A%20%20SELECT%20%3Fvirus%20%3Fwork%20WHERE%20%7B%0A%20%20%20%20VALUES%20%3Fvirus%20%7B%0A%20%20%20%20%20%20wd%3AQ82069695%20%23%20SARS-CoV-2%0A%20%20%20%20%20%20wd%3AQ16983360%20%23%20HKU1%0A%20%20%20%20%20%20wd%3AQ16991954%20%23%20OC43%0A%20%20%20%20%20%20wd%3AQ8351095%20%20%23%20NL63%20%0A%20%20%20%20%20%20wd%3AQ16983356%20%23%20229E%20%0A%20%20%20%20%20%20wd%3AQ4902157%20%20%23%20MERS-CoV%0A%20%20%20%20%20%20wd%3AQ278567%20%20%20%23%20SARS-CoV%0A%20%20%20%20%7D%0A%20%20%20%20%3Fwork%20wdt%3AP921%20%3Fvirus%20%3B%0A%20%20%20%20%20%20%20%20%20%20wdt%3AP921%20wd%3AQ79460%20.%0A%20%20%7D%0A%7D%20AS%20%25ARTICLES%20WHERE%20%7B%0A%20%20INCLUDE%20%25ARTICLES%0A%20%20SERVICE%20wikibase%3Alabel%20%7B%20bd%3AserviceParam%20wikibase%3Alanguage%20%22pt%2Cen%22.%20%7D%0A%7D%0AORDER%20BY%20%3FvirusLabel%20%3Fvirus%20%3FworkLabel%20%3Fwork%0A))

```sparql
SELECT ?virus ?virusLabel ?work ?workLabel WITH {
  SELECT ?virus ?work WHERE {
    VALUES ?virus {
      wd:Q82069695 # SARS-CoV-2
      wd:Q16983360 # HKU1
      wd:Q16991954 # OC43
      wd:Q8351095  # NL63 
      wd:Q16983356 # 229E 
      wd:Q4902157  # MERS-CoV
      wd:Q278567   # SARS-CoV
    }
    ?work wdt:P921 ?virus ;
          wdt:P921 wd:Q79460 .
  }
} AS %ARTICLES WHERE {
  INCLUDE %ARTICLES
  SERVICE wikibase:label { bd:serviceParam wikibase:language "pt,en". }
}
ORDER BY ?virusLabel ?virus ?workLabel ?work
```

A lista está crescendo bastante, então vamos mostrar somente a quantidade de artigos sobre anticorpos para cada vírus:

<table>
  <tr>
    <td><b>virus</b></td>
    <td><b>count</b></td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td>48</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q4902157">coronavírus da síndrome respiratória do Oriente Médio</a> (<a href="http://www.wikidata.org/entity/Q4902157">edit</a>)</td>
    <td>16</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q82069695">coronavírus da síndrome respiratória aguda grave 2</a> (<a href="http://www.wikidata.org/entity/Q82069695">edit</a>)</td>
    <td>13</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q16983356">Coronavírus humano 229E</a> (<a href="http://www.wikidata.org/entity/Q16983356">edit</a>)</td>
    <td>2</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q16991954">Coronavírus humano OC43</a> (<a href="http://www.wikidata.org/entity/Q16991954">edit</a>)</td>
    <td>1</td>
  </tr>
</table>

Deve-se enfatizar que os anticorpos são específicos para cada proteína e cada coronavírus tem proteínas diferentes. Essa lista, então, é apenas um agregados de artigos relevantes, mas não para se tirar conclusões imediatas.

<table>
  <tr>
    <td><b>virus</b></td>
    <td><b>work</b></td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q16983356">Coronavírus humano 229E</a> (<a href="http://www.wikidata.org/entity/Q16983356">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q40614291">Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses.</a> (<a href="http://www.wikidata.org/entity/Q40614291">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q16983356">Coronavírus humano 229E</a> (<a href="http://www.wikidata.org/entity/Q16983356">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q41288189">Detection of human coronavirus 229E-specific antibodies using recombinant fusion proteins.</a> (<a href="http://www.wikidata.org/entity/Q41288189">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q16991954">Coronavírus humano OC43</a> (<a href="http://www.wikidata.org/entity/Q16991954">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q57096902">Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43</a> (<a href="http://www.wikidata.org/entity/Q57096902">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q37033726">A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.</a> (<a href="http://www.wikidata.org/entity/Q37033726">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q45423400">A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.</a> (<a href="http://www.wikidata.org/entity/Q45423400">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q30785119">A human SARS-CoV neutralizing antibody against epitope on S2 protein</a> (<a href="http://www.wikidata.org/entity/Q30785119">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q34338054">A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies</a> (<a href="http://www.wikidata.org/entity/Q34338054">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q30230531">Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies</a> (<a href="http://www.wikidata.org/entity/Q30230531">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q47957009">An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.</a> (<a href="http://www.wikidata.org/entity/Q47957009">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q51803005">Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.</a> (<a href="http://www.wikidata.org/entity/Q51803005">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q35881133">Antibodies to SARS coronavirus in civets</a> (<a href="http://www.wikidata.org/entity/Q35881133">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q47734783">Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.</a> (<a href="http://www.wikidata.org/entity/Q47734783">edit</a>)</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q278567">SARS-CoV</a> (<a href="http://www.wikidata.org/entity/Q278567">edit</a>)</td>
    <td><a href="https://scholia.toolforge.org/Q47293237">Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid.</a> (<a href="http://www.wikidata.org/entity/Q47293237">edit</a>)</td>
  </tr>
  <tr><td colspan="2">null <a href="sparql/antibodies.code.html">sparql/antibodies.rq</a></td></tr>
</table>

## Reuso de medicamentos

A seção [8.3](#sec:trials)  inclui uma descrição geral dos ensaios clínicos. Esta aqui dá uma ideia dos sintomas que preocupam às pessoas. Também traz informações sobre quais medicamentos se estudam para <a name="tp2">reuso</a>.
Alguns destes tem recebido mais atenção, outros menos. 


<iframe
  style="width: 95%; height: 50vh; border: none;"
  src="https://query.wikidata.org/embed.html#%23defaultView%3AImageGrid%0ASELECT%20%3Fintervention%20%3FinterventionLabel%20%3Fimage%20WITH%20%7B%0A%20%20SELECT%20DISTINCT%20%3Fintervention%20%28COUNT%28DISTINCT%20%3Ftrial%29%20AS%20%3Fcount%29%20WHERE%20%7B%0A%20%20%20%20VALUES%20%3Ftopic%20%7B%20wd%3AQ84263196%20wd%3AQ82069695%20%7D%0A%20%20%20%20%3Ftrial%20wdt%3AP31%20wd%3AQ30612%20%3B%0A%20%20%20%20%20%20%20%20%20%20%20wdt%3AP921%20%20%3Ftopic%20%3B%0A%20%20%20%20%20%20%20%20%20%20%20wdt%3AP4844%20%3Fintervention%20.%0A%20%20%7D%20GROUP%20BY%20%3Fintervention%0A%20%20%20%20ORDER%20BY%20DESC%28%3Fcount%29%0A%20%20%20%20LIMIT%2025%0A%7D%20AS%20%25COMPOUNDS%20WHERE%20%7B%0A%20%20INCLUDE%20%25COMPOUNDS%0A%20%20%3Fintervention%20wdt%3AP117%20%3Fimage%20.%0A%20%20SERVICE%20wikibase%3Alabel%20%7B%20bd%3AserviceParam%20wikibase%3Alanguage%20%22pt%2Cen%22.%20%7D%0A%7D%20ORDER%20BY%20DESC%28%3Fcount%29%0A%20%20LIMIT%2010%0A"

  referrerpolicy="origin"
  sandbox="allow-scripts allow-same-origin allow-popups" >
</iframe>

A busca a seguir conta o número de ensaios clínicos no Wikidata por <a name="tp3">intervenção de pesquisa</a>:

**SPARQL** [sparql/clinicalTrialsByIntervention.rq](sparql/clinicalTrialsByIntervention.code.html) ([run](https://query.wikidata.org/embed.html#SELECT%20%3Fintervention%20%3FinterventionLabel%20%28COUNT%28%3Ftrial%29%20AS%20%3Ftrials%29%20WHERE%20%7B%0A%20%20VALUES%20%3Ftopic%20%7B%0A%20%20%20%20wd%3AQ84263196%20wd%3AQ82069695%0A%20%20%7D%0A%20%20%3Ftrial%20wdt%3AP31%20wd%3AQ30612%20%3B%0A%20%20%20%20%20%20%20%20%20wdt%3AP921%20%20%3Ftopic%20%3B%0A%20%20%20%20%20%20%20%20%20wdt%3AP4844%20%3Fintervention%20.%0A%20%20SERVICE%20wikibase%3Alabel%20%7B%20bd%3AserviceParam%20wikibase%3Alanguage%20%22pt%2Cen%22.%20%7D%0A%7D%20GROUP%20BY%20%3Fintervention%20%3FinterventionLabel%0A%20%20ORDER%20BY%20DESC%28%3Ftrials%29%20ASC%28%3Fintervention%29%0A), [edit](https://query.wikidata.org/#SELECT%20%3Fintervention%20%3FinterventionLabel%20%28COUNT%28%3Ftrial%29%20AS%20%3Ftrials%29%20WHERE%20%7B%0A%20%20VALUES%20%3Ftopic%20%7B%0A%20%20%20%20wd%3AQ84263196%20wd%3AQ82069695%0A%20%20%7D%0A%20%20%3Ftrial%20wdt%3AP31%20wd%3AQ30612%20%3B%0A%20%20%20%20%20%20%20%20%20wdt%3AP921%20%20%3Ftopic%20%3B%0A%20%20%20%20%20%20%20%20%20wdt%3AP4844%20%3Fintervention%20.%0A%20%20SERVICE%20wikibase%3Alabel%20%7B%20bd%3AserviceParam%20wikibase%3Alanguage%20%22pt%2Cen%22.%20%7D%0A%7D%20GROUP%20BY%20%3Fintervention%20%3FinterventionLabel%0A%20%20ORDER%20BY%20DESC%28%3Ftrials%29%20ASC%28%3Fintervention%29%0A))

```sparql
SELECT ?intervention ?interventionLabel (COUNT(?trial) AS ?trials) WHERE {
  VALUES ?topic {
    wd:Q84263196 wd:Q82069695
  }
  ?trial wdt:P31 wd:Q30612 ;
         wdt:P921  ?topic ;
         wdt:P4844 ?intervention .
  SERVICE wikibase:label { bd:serviceParam wikibase:language "pt,en". }
} GROUP BY ?intervention ?interventionLabel
  ORDER BY DESC(?trials) ASC(?intervention)
```

Isso nos dá:

<table>
  <tr>
    <td><b>intervention</b></td>
    <td><b>trials</b></td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q421094">Hidroxicloroquina</a> (<a href="http://www.wikidata.org/entity/Q421094">edit</a>)</td>
    <td>43</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q422438">cloroquina</a> (<a href="http://www.wikidata.org/entity/Q422438">edit</a>)</td>
    <td>15</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q422585">lopinavir</a> (<a href="http://www.wikidata.org/entity/Q422585">edit</a>)</td>
    <td>15</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q422618">ritonavir</a> (<a href="http://www.wikidata.org/entity/Q422618">edit</a>)</td>
    <td>15</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q56363387">Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites</a> (<a href="http://www.wikidata.org/entity/Q56363387">edit</a>)</td>
    <td>12</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q425154">tocilizumabe</a> (<a href="http://www.wikidata.org/entity/Q425154">edit</a>)</td>
    <td>6</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q188269">interferon</a> (<a href="http://www.wikidata.org/entity/Q188269">edit</a>)</td>
    <td>4</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q207843">óxido nítrico</a> (<a href="http://www.wikidata.org/entity/Q207843">edit</a>)</td>
    <td>4</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q40207875">antiviral agent</a> (<a href="http://www.wikidata.org/entity/Q40207875">edit</a>)</td>
    <td>4</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q410074">losartan</a> (<a href="http://www.wikidata.org/entity/Q410074">edit</a>)</td>
    <td>4</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q57055">paracetamol</a> (<a href="http://www.wikidata.org/entity/Q57055">edit</a>)</td>
    <td>4</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q11426176">prednisolona</a> (<a href="http://www.wikidata.org/entity/Q11426176">edit</a>)</td>
    <td>3</td>
  </tr>
  <tr>
    <td><a href="https://scholia.toolforge.org/Q165399">azitromicina</a> (<a href="http://www.wikidata.org/entity/Q165399">edit</a>)</td>
    <td>3</td>
  </tr>
  <tr><td colspan="2">null <a href="sparql/clinicalTrialsByIntervention.code.html">sparql/clinicalTrialsByIntervention.rq</a></td></tr>
</table>

É importante destacar que essa lista só dá uma ideia de quais intervenções tiveram mais atenção que as outras. É essencial perceber que atenção NÃO é uma medida de sucesso. 

## Referências

1. <a name="citeref1"></a>Lu S, Lu S. Timely development of vaccines against SARS-CoV-2. Emerging microbes & infections. 2020 Mar 8;9(1):542–4.  doi:[10.1080/22221751.2020.1737580](https://doi.org/10.1080/22221751.2020.1737580) ([Scholia](https://scholia.toolforge.org/doi/10.1080/22221751.2020.1737580))


